Laurus Labs Q2 Profit Doubles on 33% Revenue Growth
Laurus Labs reported a consolidated net profit of ₹436.74 crore for Q2, more than doubling from the previous year, driven by a 33% rise in revenue to ₹2,206.37 crore. Growth was supported by its CDMO business and Affordable Medicine division. The company declared an interim dividend of ₹1 per share and plans to acquire a 60% stake in Canadian firm Galenvs Sciences Inc. for $3.75 million.
Hindu Business··Hyderabad


